Attached files

file filename
10-K - ISTA PHARMACEUTICALS, INC. FORM 10-K - ISTA PHARMACEUTICALS INCd10k.htm
EX-31.2 - CERTIFICATION OF CFO - SECTION 302 - ISTA PHARMACEUTICALS INCdex312.htm
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ISTA PHARMACEUTICALS INCdex231.htm
EX-31.1 - CERTIFICATION OF CEO - SECTION 302 - ISTA PHARMACEUTICALS INCdex311.htm
EX-32.2 - CERTIFICATION OF CFO - SECTION 906 - ISTA PHARMACEUTICALS INCdex322.htm
EX-10.40 - AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT - ISTA PHARMACEUTICALS INCdex1040.htm
EX-10.10 - FIRST AMENDMENT TO LEASE DATED OCTOBER 21, 2010 - ISTA PHARMACEUTICALS INCdex1010.htm
EX-23.2 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - ISTA PHARMACEUTICALS INCdex232.htm

EXHIBIT 32.1

Certification

I, Vicente Anido, Jr., Ph.D., President and Chief Executive Officer of ISTA Pharmaceuticals, Inc. (the “Company”), certify, pursuant to Rule 13(a)-14(b) or Rule 15(d)-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that:

(1) the Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 25, 2011

 

/S/ VICENTE ANIDO, JR., PH.D.

Vicente Anido, Jr., Ph.D.,

President and Chief Executive Officer